Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1969 7
1970 4
1971 4
1972 11
1973 7
1974 5
1975 1
1976 2
1977 2
1978 5
1979 3
1980 4
1981 1
1982 4
1983 1
1984 4
1985 2
1986 3
1987 3
1988 3
1990 2
1991 2
1992 2
1993 2
1994 1
1995 4
1996 2
1997 1
1998 3
1999 2
2001 4
2002 5
2003 3
2004 4
2005 5
2006 1
2007 1
2008 1
2009 1
2010 1
2011 3
2012 4
2013 1
2014 3
2015 3
2016 1
2019 3
2022 1
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
When Can a Salvage Therapy (T-DM1) Take the Lead?
Mahtani RL, Vogel CL. Mahtani RL, et al. Among authors: vogel cl. J Clin Oncol. 2016 Oct 10;34(29):3492-3494. doi: 10.1200/JCO.2016.68.4241. J Clin Oncol. 2016. PMID: 27432926 No abstract available.
Treatment of metastatic breast cancer.
Vogel CL. Vogel CL. Semin Oncol Nurs. 1991 Aug;7(3):194-9. doi: 10.1016/0749-2081(91)90032-k. Semin Oncol Nurs. 1991. PMID: 1718024 Review.
Dual HER2-targeted approaches in HER2-positive breast cancer.
Ahn ER, Vogel CL. Ahn ER, et al. Among authors: vogel cl. Breast Cancer Res Treat. 2012 Jan;131(2):371-83. doi: 10.1007/s10549-011-1781-y. Epub 2011 Sep 29. Breast Cancer Res Treat. 2012. PMID: 21956210 Review.
Toremifene for breast cancer: a review of 20 years of data.
Vogel CL, Johnston MA, Capers C, Braccia D. Vogel CL, et al. Clin Breast Cancer. 2014 Feb;14(1):1-9. doi: 10.1016/j.clbc.2013.10.014. Epub 2013 Oct 31. Clin Breast Cancer. 2014. PMID: 24439786 Free article. Review.
Pneumocystis carinii pneumonia.
Vogel CL, Cohen MH, Powell RD Jr, DeVita VT. Vogel CL, et al. Ann Intern Med. 1968 Jan;68(1):97-108. doi: 10.7326/0003-4819-68-1-97. Ann Intern Med. 1968. PMID: 5299825 No abstract available.
144 results